https://stock.noler.com/us/stock/dna https://stock.noler.com/us/stock/dna/13f-holdings https://stock.noler.com/us/stock/dna/accounts-payable https://stock.noler.com/us/stock/dna/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/dna/accounts-receivable https://stock.noler.com/us/stock/dna/accounts-receivable-net https://stock.noler.com/us/stock/dna/accounts-receivable-related-parties https://stock.noler.com/us/stock/dna/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/dna/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/dna/accrued-liabilities-current https://stock.noler.com/us/stock/dna/accrued-professional-fees-current https://stock.noler.com/us/stock/dna/accumulated-depreciation https://stock.noler.com/us/stock/dna/acquired-cash-and-equivalents https://stock.noler.com/us/stock/dna/acquired-current-assets-receivables https://stock.noler.com/us/stock/dna/acquired-current-liabilities-deferred-revenue https://stock.noler.com/us/stock/dna/acquired-current-liabilities-long-term-debt https://stock.noler.com/us/stock/dna/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/dna/acquired-intangibles https://stock.noler.com/us/stock/dna/acquired-other-noncurrent-assets https://stock.noler.com/us/stock/dna/acquired-property-plant-and-equipment https://stock.noler.com/us/stock/dna/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/dna/acquisition-consideration-transferred https://stock.noler.com/us/stock/dna/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-asset https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-arrangements-change-in-the-range-of-outcomes-contingent-consideration-liability-value-high https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-asset https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/dna/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/dna/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-less-noncontrolling-interest https://stock.noler.com/us/stock/dna/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/dna/acquisitions https://stock.noler.com/us/stock/dna/activist-13d-13g https://stock.noler.com/us/stock/dna/additional-paid-in-capital https://stock.noler.com/us/stock/dna/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/dna/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/dna/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/dna/amended-reports-10-k https://stock.noler.com/us/stock/dna/amortization https://stock.noler.com/us/stock/dna/amortization-of-acquisition-costs https://stock.noler.com/us/stock/dna/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/dna/analyst-ratings-buy https://stock.noler.com/us/stock/dna/analyst-ratings-hold https://stock.noler.com/us/stock/dna/analyst-ratings-no-rating https://stock.noler.com/us/stock/dna/analyst-ratings-sell https://stock.noler.com/us/stock/dna/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/dna/aoci https://stock.noler.com/us/stock/dna/asset-acquisition-consideration-transferred https://stock.noler.com/us/stock/dna/asset-acquisition-consideration-transferred-contingent-consideration https://stock.noler.com/us/stock/dna/asset-impairment-charges https://stock.noler.com/us/stock/dna/assets-fair-value-disclosure https://stock.noler.com/us/stock/dna/assets-held-in-trust https://stock.noler.com/us/stock/dna/assets-held-in-trust-noncurrent https://stock.noler.com/us/stock/dna/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/dna/auditor https://stock.noler.com/us/stock/dna/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/dna/available-for-sale-debt-gross-unrealized-gain https://stock.noler.com/us/stock/dna/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/dna/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/dna/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/dna/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/dna/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/dna/available-for-sale-debt-securities https://stock.noler.com/us/stock/dna/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/dna/basic-shares https://stock.noler.com/us/stock/dna/business https://stock.noler.com/us/stock/dna/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/dna/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/dna/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/dna/business-acquisitions-purchase-price-allocation-year-of-acquisition-net-effect-on-income https://stock.noler.com/us/stock/dna/buybacks-payments-for-repurchase-of-equity https://stock.noler.com/us/stock/dna/buybacks-share-repurchases https://stock.noler.com/us/stock/dna/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/dna/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/dna/capital-expenditures https://stock.noler.com/us/stock/dna/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/dna/capital-lease-obligations-current https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/dna/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/dna/cash https://stock.noler.com/us/stock/dna/cash-acquired-from-acquisition https://stock.noler.com/us/stock/dna/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/dna/cash-and-equivalents https://stock.noler.com/us/stock/dna/cash-and-restricted-cash https://stock.noler.com/us/stock/dna/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/dna/cash-fdic-insured-amount https://stock.noler.com/us/stock/dna/cash-flow-breakdown https://stock.noler.com/us/stock/dna/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/dna/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/dna/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/dna/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/dna/clinical-trials https://stock.noler.com/us/stock/dna/co-selected-measure-amt https://stock.noler.com/us/stock/dna/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/dna/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/dna/common-stock-value https://stock.noler.com/us/stock/dna/company-guidance https://stock.noler.com/us/stock/dna/company-profile https://stock.noler.com/us/stock/dna/comprehensive-income https://stock.noler.com/us/stock/dna/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/dna/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/dna/construction-in-progress-gross https://stock.noler.com/us/stock/dna/contingent-consideration-classified-as-equity-fair-value-disclosure https://stock.noler.com/us/stock/dna/contract-liability https://stock.noler.com/us/stock/dna/contract-with-customer-asset-net https://stock.noler.com/us/stock/dna/contract-with-customer-liability-change-in-timeframe-performance-obligation-satisfied-revenue-recognized https://stock.noler.com/us/stock/dna/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-measure-of-progress https://stock.noler.com/us/stock/dna/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/dna/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/dna/convertible-securities-retired https://stock.noler.com/us/stock/dna/cost-of-revenue https://stock.noler.com/us/stock/dna/costs-and-expenses https://stock.noler.com/us/stock/dna/current-assets https://stock.noler.com/us/stock/dna/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/dna/current-income-tax-expense-benefit https://stock.noler.com/us/stock/dna/current-liabilities https://stock.noler.com/us/stock/dna/current-ratio https://stock.noler.com/us/stock/dna/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/dna/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/dna/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/dna/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/dna/debt-equity-ratio https://stock.noler.com/us/stock/dna/debt-fair-value https://stock.noler.com/us/stock/dna/debt-increase-accrued-interest https://stock.noler.com/us/stock/dna/deconsolidation-gain-or-loss-amount https://stock.noler.com/us/stock/dna/deferred-costs https://stock.noler.com/us/stock/dna/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/dna/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/dna/deferred-income https://stock.noler.com/us/stock/dna/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/dna/deferred-income-tax-liabilities https://stock.noler.com/us/stock/dna/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/dna/deferred-offering-costs https://stock.noler.com/us/stock/dna/deferred-purchased-power-costs https://stock.noler.com/us/stock/dna/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/dna/deferred-revenue https://stock.noler.com/us/stock/dna/deferred-revenue-2 https://stock.noler.com/us/stock/dna/deferred-revenue-noncurrent https://stock.noler.com/us/stock/dna/deferred-revenue-recognized https://stock.noler.com/us/stock/dna/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/dna/deferred-tax-assets-gross https://stock.noler.com/us/stock/dna/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/dna/deferred-tax-assets-net https://stock.noler.com/us/stock/dna/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/dna/deferred-tax-assets-other https://stock.noler.com/us/stock/dna/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/dna/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/dna/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/dna/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/dna/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-returns-and-allowances https://stock.noler.com/us/stock/dna/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/dna/deferred-tax-liabilities https://stock.noler.com/us/stock/dna/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/dna/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/dna/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/dna/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/dna/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/dna/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/dna/depreciation https://stock.noler.com/us/stock/dna/depreciation-and-amortization-expense https://stock.noler.com/us/stock/dna/diluted-shares https://stock.noler.com/us/stock/dna/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/dna/dividend https://stock.noler.com/us/stock/dna/dividend-safety https://stock.noler.com/us/stock/dna/dividends-declared https://stock.noler.com/us/stock/dna/due-from-related-parties-current https://stock.noler.com/us/stock/dna/due-to-related-parties-current https://stock.noler.com/us/stock/dna/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/dna/ebitda https://stock.noler.com/us/stock/dna/ebitda-margin https://stock.noler.com/us/stock/dna/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/dna/effective-tax-rate https://stock.noler.com/us/stock/dna/employee-count https://stock.noler.com/us/stock/dna/employee-related-liabilities-current https://stock.noler.com/us/stock/dna/employee-stock-ownership-plan-esop-debt-structure-direct-loan-employer-cash-payments-used-for-debt-service https://stock.noler.com/us/stock/dna/eps https://stock.noler.com/us/stock/dna/eps-basic https://stock.noler.com/us/stock/dna/equity-method-investment-other-than-temporary-impairment https://stock.noler.com/us/stock/dna/equity-method-investments https://stock.noler.com/us/stock/dna/equity-securities-fv-ni-and-without-readily-determinable-fair-value https://stock.noler.com/us/stock/dna/equity-securities-fv-ni-gain-loss https://stock.noler.com/us/stock/dna/equity-securities-fv-ni-realized-gain-loss https://stock.noler.com/us/stock/dna/equity-securities-fv-ni-unrealized-gain-loss https://stock.noler.com/us/stock/dna/equity-securities-without-readily-determinable-fair-value-amount https://stock.noler.com/us/stock/dna/equity-securities-without-readily-determinable-fair-value-downward-price-adjustment-annual-amount https://stock.noler.com/us/stock/dna/equity-securities-without-readily-determinable-fair-value-downward-price-adjustment-cumulative-amount https://stock.noler.com/us/stock/dna/equity-securities-without-readily-determinable-fair-value-impairment-loss-annual-amount https://stock.noler.com/us/stock/dna/equity-securities-without-readily-determinable-fair-value-impairment-loss-cumulative-amount https://stock.noler.com/us/stock/dna/equity-securities-without-readily-determinable-fair-value-upward-price-adjustment-annual-amount https://stock.noler.com/us/stock/dna/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/dna/executive-pay-pvp https://stock.noler.com/us/stock/dna/executive-salary-officers https://stock.noler.com/us/stock/dna/expense-breakdown https://stock.noler.com/us/stock/dna/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/dna/fair-value-option-aggregate-differences-long-term-debt-instruments https://stock.noler.com/us/stock/dna/fair-value-option-changes-in-fair-value-gain-loss https://stock.noler.com/us/stock/dna/finance-lease-interest-expense https://stock.noler.com/us/stock/dna/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/dna/finance-lease-liability https://stock.noler.com/us/stock/dna/finance-lease-liability-current https://stock.noler.com/us/stock/dna/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/dna/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/dna/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/dna/finance-lease-principal-payments https://stock.noler.com/us/stock/dna/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/dna/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/dna/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/dna/financing-cash-flow https://stock.noler.com/us/stock/dna/financing-receivable-excluding-accrued-interest-after-allowance-for-credit-loss https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-rolling-after-year-five https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-rolling-year-five https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-rolling-year-four https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-rolling-year-three https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-rolling-year-two https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/dna/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/dna/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/dna/foreign-pretax-income https://stock.noler.com/us/stock/dna/form-144-stocks https://stock.noler.com/us/stock/dna/form-n-port-stocks https://stock.noler.com/us/stock/dna/gain-loss-on-contract-termination https://stock.noler.com/us/stock/dna/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/dna/gain-loss-on-investments https://stock.noler.com/us/stock/dna/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/dna/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/dna/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/dna/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/dna/general-and-administrative-expense https://stock.noler.com/us/stock/dna/goodwill https://stock.noler.com/us/stock/dna/goodwill-acquired https://stock.noler.com/us/stock/dna/goodwill-change https://stock.noler.com/us/stock/dna/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/dna/goodwill-impairment-loss https://stock.noler.com/us/stock/dna/goodwill-other-increase-decrease https://stock.noler.com/us/stock/dna/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/dna/graph https://stock.noler.com/us/stock/dna/gross-margin https://stock.noler.com/us/stock/dna/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/dna/impairment-of-investments https://stock.noler.com/us/stock/dna/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/dna/included-in-etf https://stock.noler.com/us/stock/dna/income-loss-from https://stock.noler.com/us/stock/dna/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/dna/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/dna/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/dna/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/dna/income-loss-from-per-basic-share https://stock.noler.com/us/stock/dna/income-tax https://stock.noler.com/us/stock/dna/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/dna/income-tax-paid-federal-after-refund-received https://stock.noler.com/us/stock/dna/income-tax-paid-foreign-after-refund-received https://stock.noler.com/us/stock/dna/income-taxes-paid https://stock.noler.com/us/stock/dna/income-taxes-paid-2 https://stock.noler.com/us/stock/dna/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/dna/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/dna/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/dna/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/dna/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/dna/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/dna/increase-decrease-in-inventories https://stock.noler.com/us/stock/dna/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/dna/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/dna/increase-decrease-in-other-current-assets-and-liabilities-net https://stock.noler.com/us/stock/dna/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/dna/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/dna/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/dna/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/dna/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/dna/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/dna/incremental-common-shares-attributable-to-contingently-issuable-shares https://stock.noler.com/us/stock/dna/indefinite-lived-intangible-assets-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/dna/indefinitelived-intangible-assets-acquired https://stock.noler.com/us/stock/dna/insider-transactions https://stock.noler.com/us/stock/dna/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/dna/interest-expense https://stock.noler.com/us/stock/dna/interest-expense-nonoperating https://stock.noler.com/us/stock/dna/interest-income-expense-net https://stock.noler.com/us/stock/dna/interest-income-other https://stock.noler.com/us/stock/dna/interest-income-related-party https://stock.noler.com/us/stock/dna/interest-income-securities-us-treasury-and-other-us-government https://stock.noler.com/us/stock/dna/interest-paid https://stock.noler.com/us/stock/dna/interest-paid-net https://stock.noler.com/us/stock/dna/inventory https://stock.noler.com/us/stock/dna/inventory-finished-goods https://stock.noler.com/us/stock/dna/inventory-raw-materials https://stock.noler.com/us/stock/dna/inventory-valuation-reserves https://stock.noler.com/us/stock/dna/inventory-work-in-process https://stock.noler.com/us/stock/dna/investing-cash-flow https://stock.noler.com/us/stock/dna/investment-income-interest https://stock.noler.com/us/stock/dna/investments https://stock.noler.com/us/stock/dna/iran-activity-notices-irannotice https://stock.noler.com/us/stock/dna/labor-and-related-expense https://stock.noler.com/us/stock/dna/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/dna/lease-and-rental-expense https://stock.noler.com/us/stock/dna/lease-cost https://stock.noler.com/us/stock/dna/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/dna/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/dna/level-3-asset-change https://stock.noler.com/us/stock/dna/level-3-asset-gain-loss-included-in-earnings https://stock.noler.com/us/stock/dna/level-3-asset-issues https://stock.noler.com/us/stock/dna/level-3-asset-purchases https://stock.noler.com/us/stock/dna/level-3-asset-settlements https://stock.noler.com/us/stock/dna/level-3-asset-value https://stock.noler.com/us/stock/dna/liabilities-fair-value-adjustment https://stock.noler.com/us/stock/dna/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/dna/line-of-credit-facility-increase-decrease-for-period-net https://stock.noler.com/us/stock/dna/loans-receivable-fair-value-disclosure https://stock.noler.com/us/stock/dna/loss-on-contracts https://stock.noler.com/us/stock/dna/market-cap https://stock.noler.com/us/stock/dna/marketable-securities https://stock.noler.com/us/stock/dna/marketable-securities-current https://stock.noler.com/us/stock/dna/material-contracts https://stock.noler.com/us/stock/dna/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/dna/minority-interest https://stock.noler.com/us/stock/dna/net-cash-from-operating-activities https://stock.noler.com/us/stock/dna/net-change-in-cash https://stock.noler.com/us/stock/dna/net-income https://stock.noler.com/us/stock/dna/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/dna/net-income-loss-from-available-to-common-shareholders-basic https://stock.noler.com/us/stock/dna/net-income-loss-from-available-to-common-shareholders-diluted https://stock.noler.com/us/stock/dna/net-margin https://stock.noler.com/us/stock/dna/net-rentable-area https://stock.noler.com/us/stock/dna/news https://stock.noler.com/us/stock/dna/non-peo-neo-avg-comp-actually-paid-amt https://stock.noler.com/us/stock/dna/non-peo-neo-avg-total-comp-amt https://stock.noler.com/us/stock/dna/noncontrolling-interest-decrease-from-deconsolidation https://stock.noler.com/us/stock/dna/noncontrolling-interest-increase-from-business-combination https://stock.noler.com/us/stock/dna/noncontrolling-interest-increase-from-subsidiary-equity-issuance https://stock.noler.com/us/stock/dna/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/dna/notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/dna/notes-payable-current https://stock.noler.com/us/stock/dna/notes-receivable-fair-value-disclosure https://stock.noler.com/us/stock/dna/notes-receivable-related-parties https://stock.noler.com/us/stock/dna/number-of-operating-segments https://stock.noler.com/us/stock/dna/number-of-reportable-segments https://stock.noler.com/us/stock/dna/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/dna/oci-foreign-currency-transaction-and-translation-adjustment-before-tax https://stock.noler.com/us/stock/dna/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/dna/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/dna/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/dna/oci-foreign-currency-transaction-and-translation-reclassification-adjustment-from-aoci-realized-upon-sale-or-liquidation-net-of-tax https://stock.noler.com/us/stock/dna/oci-net-of-tax https://stock.noler.com/us/stock/dna/oci-net-of-tax-2 https://stock.noler.com/us/stock/dna/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/dna/operating-cash-flow https://stock.noler.com/us/stock/dna/operating-expenses https://stock.noler.com/us/stock/dna/operating-income https://stock.noler.com/us/stock/dna/operating-lease-assets https://stock.noler.com/us/stock/dna/operating-lease-cost https://stock.noler.com/us/stock/dna/operating-lease-expense https://stock.noler.com/us/stock/dna/operating-lease-impairment-loss https://stock.noler.com/us/stock/dna/operating-lease-liability https://stock.noler.com/us/stock/dna/operating-lease-liability-current https://stock.noler.com/us/stock/dna/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/dna/operating-lease-payments https://stock.noler.com/us/stock/dna/operating-lease-payments-due https://stock.noler.com/us/stock/dna/operating-lease-payments-due-2 https://stock.noler.com/us/stock/dna/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/dna/operating-lease-payments-due-current https://stock.noler.com/us/stock/dna/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/dna/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/dna/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/dna/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/dna/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/dna/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/dna/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/dna/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/dna/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/dna/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/dna/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/dna/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/dna/operating-leases-rent-expense-net https://stock.noler.com/us/stock/dna/operating-margin https://stock.noler.com/us/stock/dna/options-activity https://stock.noler.com/us/stock/dna/other-accrued-liabilities-current https://stock.noler.com/us/stock/dna/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/dna/other-current-assets https://stock.noler.com/us/stock/dna/other-current-liabilities https://stock.noler.com/us/stock/dna/other-noncash-income-expense https://stock.noler.com/us/stock/dna/other-noncurrent-assets https://stock.noler.com/us/stock/dna/other-noncurrent-liabilities https://stock.noler.com/us/stock/dna/other-nonoperating-income-expense https://stock.noler.com/us/stock/dna/other-operating-income-expense-net https://stock.noler.com/us/stock/dna/other-receivables https://stock.noler.com/us/stock/dna/outstanding-bonds https://stock.noler.com/us/stock/dna/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/dna/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/dna/paid-in-capital-equity-component-of-convertible-debt-subsequent-adjustments https://stock.noler.com/us/stock/dna/paid-in-capital-other https://stock.noler.com/us/stock/dna/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/dna/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/dna/paid-in-capital-stock-split https://stock.noler.com/us/stock/dna/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/dna/patents-active https://stock.noler.com/us/stock/dna/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/dna/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/dna/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/dna/payments-for-underwriting-expense https://stock.noler.com/us/stock/dna/payments-of-financing-costs https://stock.noler.com/us/stock/dna/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/dna/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/dna/payments-to-acquire-equity-securities-fv-ni https://stock.noler.com/us/stock/dna/payments-to-acquire-finance-receivables https://stock.noler.com/us/stock/dna/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/dna/payments-to-acquire-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/dna/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/dna/payments-to-acquire-restricted-investments https://stock.noler.com/us/stock/dna/pb-ratio https://stock.noler.com/us/stock/dna/pe-ratio https://stock.noler.com/us/stock/dna/peer-group-total-shareholder-rtn-amt https://stock.noler.com/us/stock/dna/peo-actually-paid-comp-amt https://stock.noler.com/us/stock/dna/peo-total-comp-amt https://stock.noler.com/us/stock/dna/pre-tax-margin https://stock.noler.com/us/stock/dna/preferred-shares-facts https://stock.noler.com/us/stock/dna/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/dna/preferred-stock-shares-authorized https://stock.noler.com/us/stock/dna/preferred-stock-shares-issued https://stock.noler.com/us/stock/dna/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/dna/preferred-stock-value https://stock.noler.com/us/stock/dna/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/dna/prepaid-expense-current https://stock.noler.com/us/stock/dna/prepaid-insurance https://stock.noler.com/us/stock/dna/pretax-income https://stock.noler.com/us/stock/dna/pretax-income-domestic https://stock.noler.com/us/stock/dna/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/dna/previous-etf-holding-it https://stock.noler.com/us/stock/dna/price-fcf-ratio https://stock.noler.com/us/stock/dna/proceeds-from-collection-of-notes-receivable https://stock.noler.com/us/stock/dna/proceeds-from-convertible-debt https://stock.noler.com/us/stock/dna/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/dna/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/dna/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/dna/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/dna/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/dna/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/dna/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/dna/proceeds-from-related-party-debt https://stock.noler.com/us/stock/dna/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/dna/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/dna/proceeds-from-sale-of-land-held-for-use https://stock.noler.com/us/stock/dna/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/dna/proceeds-from-sale-of-other-investments https://stock.noler.com/us/stock/dna/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/dna/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/dna/proceeds-from-sales-of-business-affiliate-and-productive-assets https://stock.noler.com/us/stock/dna/proceeds-from-stock-issued https://stock.noler.com/us/stock/dna/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/dna/profit-breakdown https://stock.noler.com/us/stock/dna/profit-loss https://stock.noler.com/us/stock/dna/property-plant-and-equipment-gross https://stock.noler.com/us/stock/dna/property-plant-equipment https://stock.noler.com/us/stock/dna/provision-for-lease-losses https://stock.noler.com/us/stock/dna/ps-ratio https://stock.noler.com/us/stock/dna/public-float https://stock.noler.com/us/stock/dna/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/dna/purchase-obligations-balance-on-fifth-anniversary https://stock.noler.com/us/stock/dna/purchase-obligations-balance-on-first-anniversary https://stock.noler.com/us/stock/dna/purchase-obligations-balance-on-fourth-anniversary https://stock.noler.com/us/stock/dna/purchase-obligations-balance-on-second-anniversary https://stock.noler.com/us/stock/dna/purchase-obligations-balance-on-third-anniversary https://stock.noler.com/us/stock/dna/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/dna/purchase-obligations-purchases https://stock.noler.com/us/stock/dna/quick-ratio https://stock.noler.com/us/stock/dna/receivables-fair-value-disclosure https://stock.noler.com/us/stock/dna/redeemable-noncontrolling-interest-equity-carrying-amount https://stock.noler.com/us/stock/dna/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/dna/research-and-development https://stock.noler.com/us/stock/dna/research-and-development-in-process https://stock.noler.com/us/stock/dna/restricted-cash https://stock.noler.com/us/stock/dna/restricted-cash-current https://stock.noler.com/us/stock/dna/restricted-cash-equivalents-noncurrent https://stock.noler.com/us/stock/dna/restricted-cash-noncurrent https://stock.noler.com/us/stock/dna/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/dna/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/dna/restructuring-charges https://stock.noler.com/us/stock/dna/restructuring-costs https://stock.noler.com/us/stock/dna/restructuring-costs-and-asset-impairment-charges https://stock.noler.com/us/stock/dna/restructuring-reserve https://stock.noler.com/us/stock/dna/retained-earnings https://stock.noler.com/us/stock/dna/return-on-tangible-equity https://stock.noler.com/us/stock/dna/revenue https://stock.noler.com/us/stock/dna/revenue-breakdown https://stock.noler.com/us/stock/dna/revenue-from-related-parties https://stock.noler.com/us/stock/dna/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/dna/revenue-remaining-performance-obligation-percentage https://stock.noler.com/us/stock/dna/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/dna/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/dna/roa https://stock.noler.com/us/stock/dna/roe https://stock.noler.com/us/stock/dna/roi https://stock.noler.com/us/stock/dna/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/dna/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/dna/scorecard https://stock.noler.com/us/stock/dna/sec-comment-letters-upload https://stock.noler.com/us/stock/dna/sec-enforcement-actions https://stock.noler.com/us/stock/dna/sec-filings-10-q https://stock.noler.com/us/stock/dna/sec-filings-25-nse https://stock.noler.com/us/stock/dna/sec-filings-8-k https://stock.noler.com/us/stock/dna/sec-filings-px14a6g https://stock.noler.com/us/stock/dna/sec-filings-s-4 https://stock.noler.com/us/stock/dna/secondary-offerings https://stock.noler.com/us/stock/dna/security-deposit https://stock.noler.com/us/stock/dna/severance-costs https://stock.noler.com/us/stock/dna/share-price https://stock.noler.com/us/stock/dna/shareholders-equity https://stock.noler.com/us/stock/dna/shares-authorized https://stock.noler.com/us/stock/dna/shares-issued https://stock.noler.com/us/stock/dna/shares-outstanding https://stock.noler.com/us/stock/dna/short-sale-volume https://stock.noler.com/us/stock/dna/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/dna/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/dna/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/dna/stock-award-fair-value-assumptions-weighted-average-expected-dividend https://stock.noler.com/us/stock/dna/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/dna/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/dna/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/dna/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/dna/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/dna/stock-award-rsu-share-based-liabilities-paid https://stock.noler.com/us/stock/dna/stock-based-compensation https://stock.noler.com/us/stock/dna/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/dna/stock-issued-new-shares-sold https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-shares-restricted-stock-award-forfeited https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/dna/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/dna/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/dna/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/dna/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/dna/stock-options-exercisable-number https://stock.noler.com/us/stock/dna/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/dna/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/dna/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/dna/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/dna/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/dna/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/dna/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/dna/stock-options-outstanding-number https://stock.noler.com/us/stock/dna/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/dna/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/dna/stock-redeemed-or-called-value https://stock.noler.com/us/stock/dna/stock-repurchase-program-remaining-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/dna/stock-split-ratio https://stock.noler.com/us/stock/dna/stock-splits https://stock.noler.com/us/stock/dna/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/dna/straight-line-rent https://stock.noler.com/us/stock/dna/sublease-income https://stock.noler.com/us/stock/dna/subsidiaries https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-equity-in-earnings-losses-of-unconsolidated-subsidiary https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/dna/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/dna/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/dna/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/dna/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/dna/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/dna/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/dna/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/dna/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/dna/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/dna/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/dna/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/dna/temporary-equity-shares-issued https://stock.noler.com/us/stock/dna/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/dna/total-assets https://stock.noler.com/us/stock/dna/total-contract-liability https://stock.noler.com/us/stock/dna/total-liabilities https://stock.noler.com/us/stock/dna/total-liabilities-and-equity https://stock.noler.com/us/stock/dna/total-shareholder-rtn-amt https://stock.noler.com/us/stock/dna/transfers-of-financial-assets-accounted-for-as-sale-initial-fair-value-of-liabilities-incurred https://stock.noler.com/us/stock/dna/treasury-stock-common-shares https://stock.noler.com/us/stock/dna/unbilled-contracts-receivable https://stock.noler.com/us/stock/dna/unrecognized-tax-benefits https://stock.noler.com/us/stock/dna/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/dna/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/dna/variable-interest-entity-ownership-percentage https://stock.noler.com/us/stock/dna/variable-lease-cost https://stock.noler.com/us/stock/dna/warrants-and-rights-outstanding https://stock.noler.com/us/stock/dna/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/dna/weighted-average-number-of-shares-contingently-issuable